130707-81-2

Basic information

• Product Name: 1,4,7,10-tetraaza-1-N-(1-carbomethoxy-3-(4-nitrophenyl)propyl)cyclododecane
• Synonyms: 1,4,7,10-tetraaza-1-N-(1-carbomethoxy-3-(4-nitrophenyl)propyl)cyclododecane
• CAS NO: 130707-81-2
• Molecular Weight: 393.486
• Mol File: 130707-81-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1,4,7,10-tetraaza-1-N-(1-carbomethoxy-3-(4-nitrophenyl)propyl)cyclododecane(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4,7,10-tetraaza-1-N-(1-carbomethoxy-3-(4-nitrophenyl)propyl)cyclododecane(130707-81-2)
• EPA Substance Registry System: 1,4,7,10-tetraaza-1-N-(1-carbomethoxy-3-(4-nitrophenyl)propyl)cyclododecane(130707-81-2)

Safety Data

• Hazardous Substances Data: 130707-81-2(Hazardous Substances Data)

Upstream product

• 294-90-6 1,4,7,10-tetraazacyclododecan 
• 130707-80-1 d,l-2-bromo-4-(4-nitrophenyl)butanoic acid methyl ester 
• 67-56-1 methanol 
• 5600-62-4 4-(4-nitrophenyl)butanoic acid 

Downstream Products

• 596121-76-5 C₄₀H₆₁N₅O₁₆ 
• 130707-73-2 α-[2-(4-nitrophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,7,10-tetramethyl ester 
• 259088-63-6 1,4,7,10-tetraaza-N-(1-carbomethoxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tris(acetic acid, ethyl ester)cyclododecane 
• 130707-75-4 α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid 

Relevant articles and documents

Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates

The invention relates to high-relaxivity macrocyclic gadolinium chelate oligomers of formula [in-line-formulae]W-(A)m[/in-line-formulae] in which W, A and m are as defined in claim 1, and their use as a blood pool contrast product for magnetic resonance imaging.

Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents

A group conjugates having a functionalized polyaminocarboxylate chelant that form complexes with rare earth-type metal ions, covalently attached to an antibody or antibody fragment, can be used for therapeutic and/or diagnostic purposes.

Process for preparing mono-n-alkylated polyazamacrocycles

The invention relates to a novel process to prepare selectively mono-N-alkylated polyazamacrocycles which requires an electrophile with between about one and five equivalents of a suitable macrocycle in a solvent which will not promote a proton transfer.